Medical Success Story: Successful First MTEER Procedure in Structural Heart Care
We are proud to announce this remarkable medical achievement, as our Heart Team successfully performed the institution’s first Mitral Transcatheter Edge-to-Edge Repair (MTEER) using the MitraClip system.
The New Frontier in Advanced Cardiac Interventions
This milestone marks a new benchmark in advanced cardiac care, highlighting the role of innovation, precision, and multidisciplinary collaboration in treating complex structural heart disease.
A Cycle of Crisis
The patient, a 57-year-old African male, had a history of chronic heart failure and atrial fibrillation, with repeated admissions for acute decompensated heart failure and pulmonary edema.
A Devastating Quality of Life
Despite maximal Guideline-Directed Medical Therapy (GDMT), his condition continued to deteriorate. He experienced severe shortness of breath, marked limitation in daily activities, and loss of independence.
Exhausted Options
Electrophysiology interventions including catheter ablation and CRT-D were considered but not pursued due to severely reduced left ventricular function and severe mitral regurgitation.
Surgical mitral valve repair was also deemed high-risk given his advanced heart failure and fragile clinical state.
The patient was therefore considered for transcatheter edge-to-edge repair (MTEER).
The Turning Point: Imaging and Planning
The patient underwent comprehensive clinical optimization and advanced cardiac imaging using 3D and 4D TTE and TEE to assess mitral valve anatomy and confirm suitability for MitraClip intervention.
The Procedure: MitraClip Intervention
The procedure was performed under fluoroscopy and real-time 4D TEE guidance. A single MitraClip was successfully deployed, achieving effective grasping of the mitral valve leaflets.
The Outcome
Immediate results showed a reduction in mitral regurgitation (MR) from severe (4+) to mild (1+), with successful procedural outcome confirmed intraoperatively.
This first successful MTEER case represents an important advancement in structural heart disease management. It demonstrates the value of multidisciplinary collaboration, advanced imaging, and transcatheter therapies in treating high-risk patients with severe mitral regurgitation.